Eolas Therapeutics
Pre-clinicalEolas Therapeutics is a biotechnology company focused on developing novel therapies for addiction and other neurological disorders. Our mission is to improve the lives of patients by addressing unmet medical needs through innovative science and a patient-centric approach.
Founded
2018
Focus
OncologyNeuroscience
About
Eolas Therapeutics is a biotechnology company focused on developing novel therapies for addiction and other neurological disorders. Our mission is to improve the lives of patients by addressing unmet medical needs through innovative science and a patient-centric approach.
Funding History
2Total raised: $25M
Series A$20MMPM CapitalJun 15, 2021
Seed$5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2018
LocationDublin, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile